Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors

C:NRPnbhDCORXS\4502194_1 DOC-30/07/2012 The present invention provides substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors and pharmaceutical compositions containing those compounds which can be used in methods of treating, inhibiting the growth of or eradicating a neoplasm in a mam...

Full description

Saved in:
Bibliographic Details
Main Authors ZHANG, NAN, FLOYD JR., MIDDLETON BRAWNER FLOYD, TSOU, HWEI-RU, WISSNER, ALLAN, HAMANN, PHILIP ROSS, BERGER, DAN MAARTEN, FROST, PHILIP
Format Patent
LanguageEnglish
Published 26.09.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract C:NRPnbhDCORXS\4502194_1 DOC-30/07/2012 The present invention provides substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors and pharmaceutical compositions containing those compounds which can be used in methods of treating, inhibiting the growth of or eradicating a neoplasm in a mammal. The compounds and pharmaceutical compositions containing them may also be used on methods of treating, inhibiting the progression of or eradicating polycystic kidney disease in a mammal. The present invention also provides a process for preparing the compounds of this invention.
AbstractList C:NRPnbhDCORXS\4502194_1 DOC-30/07/2012 The present invention provides substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors and pharmaceutical compositions containing those compounds which can be used in methods of treating, inhibiting the growth of or eradicating a neoplasm in a mammal. The compounds and pharmaceutical compositions containing them may also be used on methods of treating, inhibiting the progression of or eradicating polycystic kidney disease in a mammal. The present invention also provides a process for preparing the compounds of this invention.
Author WISSNER, ALLAN
FROST, PHILIP
HAMANN, PHILIP ROSS
FLOYD JR., MIDDLETON BRAWNER FLOYD
ZHANG, NAN
TSOU, HWEI-RU
BERGER, DAN MAARTEN
Author_xml – fullname: ZHANG, NAN
– fullname: FLOYD JR., MIDDLETON BRAWNER FLOYD
– fullname: TSOU, HWEI-RU
– fullname: WISSNER, ALLAN
– fullname: HAMANN, PHILIP ROSS
– fullname: BERGER, DAN MAARTEN
– fullname: FROST, PHILIP
BookMark eNqNirsOwjAMADPAwOsfMrBWCskCI-UhdmCu0mKERWWH2Bn693TgA5hOuru5mRATzMzxWlpR1KLwsKHqhkj8KUjcI4HYKDZlVkCyOmSWUdo3UpSxIb2wReUsSzN9xl5g9ePCrM-n2-FSQeIGJMUOCLTZ373beO92Lmzr2oc_ty-B5TbV
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2012209038BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2012209038BB23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:34:56 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2012209038BB23
Notes Application Number: AU20120209038
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130926&DB=EPODOC&CC=AU&NR=2012209038B2
ParticipantIDs epo_espacenet_AU2012209038BB2
PublicationCentury 2000
PublicationDate 20130926
PublicationDateYYYYMMDD 2013-09-26
PublicationDate_xml – month: 09
  year: 2013
  text: 20130926
  day: 26
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies WYETH HOLDINGS CORPORATION
RelatedCompanies_xml – name: WYETH HOLDINGS CORPORATION
Score 2.9015324
Snippet C:NRPnbhDCORXS\4502194_1 DOC-30/07/2012 The present invention provides substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors and pharmaceutical...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130926&DB=EPODOC&locale=&CC=AU&NR=2012209038B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1dS8Mw8BhT1Dedil-TPIy-Fdesy9qHIbbdGMI-kE32NpomxaBkw1Zk_95L3HRP-hbu4LgE7jt3B9BocsGDNBVuy88FBiiMuWnueS7LvU7GBTq8zDQ4D0dsMPMf5-15Bd62vTB2TuinHY6IEpWhvJdWX69-k1iJ_VtZ3HGFoOV9f9pNnE10jAo5pMxJom5vMk7GsRPHGEk6oyeDo9TkJIIIFfaecaTNpP3ec2T6Ula7RqV_DPsTpKfLE6hIXYPDeLt7rQYHw03JG48b6StOITFS_l3aF6TlZutUo1pX2uzdkQVJC2KnLihNyjUaPwSSV6XRTBVE6RfFldmscwaNfm8aD1xkZ_Fz-8XDbIf3iLbOoaqXWl4AYQGVXo4ulmw3fSE4l6nn89AULsOgE2SXUP-T1NU_-Gs4onb5Q-hSdgPV8v1D1tEEl_zWvtwXjD6LSw
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1dS8Mw8BhTnG86Fb-meRh9K65Zl7UPQ2y7UXVfyCZ7G03TYlGyYSuyf-8lbronfQt3cFwC9527A6g3uOBOFAmzaacCAxTGzCi1LJOlVjvmAh1ephqcB0MWTu2HWWtWgrdNL4yeE_qphyOiRMUo74XW18vfJFag_1bmNzxD0OK2N-kExjo6RoXsUmYEXqc7HgUj3_B9jCSN4ZPCUapyEo6HCnunrebzKufp2VN9Kctto9I7gN0x0pPFIZQSWYWKv9m9VoW9wbrkjce19OVHECgp_y7tC9I041UkUa1nUu3dSXIS5URPXcgkKVZo_BBIXjOJZionmXzJeKY26xxDvded-KGJ7Mx_bj-_m27x7tHmCZTlQianQJhDEytFFytpNWwhOE8iy-auKly6TtuJz6D2J6nzf_DXUAkng_68fz98vIB9qhdBuCZll1Au3j-SGprjgl_pV_wCOJqOOA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+3-cyanoquinolines+as+protein+tyrosine+kinases+inhibitors&rft.inventor=ZHANG%2C+NAN&rft.inventor=FLOYD+JR.%2C+MIDDLETON+BRAWNER+FLOYD&rft.inventor=TSOU%2C+HWEI-RU&rft.inventor=WISSNER%2C+ALLAN&rft.inventor=HAMANN%2C+PHILIP+ROSS&rft.inventor=BERGER%2C+DAN+MAARTEN&rft.inventor=FROST%2C+PHILIP&rft.date=2013-09-26&rft.externalDBID=B2&rft.externalDocID=AU2012209038BB2